##Home
##Our advantages
##Activities survey
##Our services portfolio
Contact :

Oroxcell
Parc Biocitech
102 route de Noisy
F93230 ROMAINVILLE

Tel:00 33 (0)1 41 83 72 20

E-mail : martine.girardi@oroxcell.com
 HomeAuthentificationPrint the pageMapfr
Oroxcell
biopharmaceutical partner for Life Sciences industries

Pharma Cosmetics Food industries
Oroxcell can conduct as CRO your studies :

in vitro ADME : Caco-2, cellular assays, metabolism (S9, hepatocytes, skin assays)

Animal PK on rodents : biodistribution, bioavailability, metabolism

Phys-Chem studies : stability, solubility

Bioanalysis by LC-MS/MS

and early pre-formulation of active ingredients

All these experiments can be realised, if needed, on radioactive compound (legal agreement)


Oroxcell is developing internal research projects :

in cell culture

in innovative formulations, particularly with our patented technology.
NEWS and AWARDS

2007 : Oroxcell proposes new validated skin assays using reconstituted human skins to test the potential cutaneous corrosivity and irritation of your compounds. These assays are conducted with EPISKIN ou SKINETHIC model skins (See "our services portfolio").

2007 : Oroxcell has signed a total agency contract for Japan market with Japanese's Nosan Corporation (www.nosan.co.jp) in the medical product absorption field and started the mediation business for improvement testing of bioavailability rate. This is aimed at a substantial expansion of our Bio business reported Nosan Corporation to Reuters.
For Oroxcell, this cooperation with Nosan, in which Mitsubishi Corporation holds 21% of the total common shares, represents a very good opportunity for theintroduction to Japanese market and for sustaining the clients pipeline. This collaboration gives also an additional evidence of Oroxcell's efficacy to add value to R&D life sciences products.

2006 : Oroxcell receives a major grant from the French organisation OSEO ANVAR to push away an innovative in house project of a new molecule for the pharmaceutical market.

2006 : Oroxcell has been classified, by the French Ministry of Economics, as an Innovative Entreprise.

2006 : Oroxcell increases his formulation offer through an exclusive license of a new patented formulation technology.

2006 : Oroxcell has been elected as a young innovative entreprise (a particular financial French status permitting to speed up Oroxcell development)

2005 : Oroxcell has been honoured from the National French Master Prize of the 2005 young entrepreneur.

2004 : Oroxcell has been awarded as National French Laureate of the 2004 contest of innovative young entreprise.

For more information : Contact